Clinical TrialsSearch results
Number of results: 536
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A study of aminolevulinic acid phosphate as an aid to functional recovery in patients with sarcopenia
- Sarcopenia
- Sugimoto Ken
- 2024-09-13
Recruiting
- A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
- Newly Diagnosed Multiple Myeloma
- Gazzera Giulia
- 2022-11-25
Recruiting
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
- Breast Cancer
- Inoguchi Akihiro
- 2023-01-22
Recruiting
- A study of dostarlimab in combination with carboplatin-paclitaxel in Japanese participants with primary advanced or recurrent endometrial cancer
- Endometrial Cancer
- Ishibashi Hideyasu
- 2024-03-28
Completed
- A study of DoTiNurad aiming to treat hyperuricemia with CKD
- Patients with hyperuricemia whose renal function is in the GFR range of G1 to G4
- Wada Jun
- 2022-02-22
Other
- A Study of JNJ-64407564 in Japanese Participants with Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Fujikawa Ei
- 2021-04-01
Other
- A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma (iinnovate-1)
- Multiple Myeloma
- Asato Takayuki
- 2022-12-26
Other
- A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
- Locally Advanced, Unresectable, or Metastatic Non -Small Cell Lung Cancer
- Tsumura Akari
- 2021-09-28
Completed
- A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia
- Achondroplasia
- Kawai Norisuke
- 2022-07-07
Other
- A study of Teclistamab in Japanese Participants with Relapsed or Refractory Multiple Myeloma
- Hematologic Malignancies
- Nishikawa Kazuko
- 2021-01-29